Advertisement

Topics

Latest "HDT Engineered Technologies" News Stories

15:10 EDT 15th October 2018 | BioPortfolio

Here are the most relevant search results for "HDT Engineered Technologies" found in our extensive news archives from over 250 global news sources.

More Information about HDT Engineered Technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about HDT Engineered Technologies for you to read. Along with our medical data and news we also list HDT Engineered Technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of HDT Engineered Technologies Companies for you to search.

Showing "Engineered Technologies" News Articles 1–25 of 5,700+

Monday 15th October 2018

Osirium Technologies (158355634OSI) - Securing growth through PAM innovation

Edison Investment Research - Technology - Osirium Technologies: Osirium reported H118 results in line with management expectations. Revenue growth of 78% and bookings growth of 37% provide good support to our FY18 forecasts. Heightened M&A activity in the privileged access management (PAM) market highlights the growing importance of PAM technology in IT security and the greenfield opportunity ...


Global Biocides and Disinfectants Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

CDRD Appoints Didier Leconte to Its Board of Directors

CDRD –The Centre for Drug Research and Development, Canada’s national life sciences venture, is pleased to announce the appointment of Mr. Didier Leconte as a new Director of the organization. Mr. Leconte is Vice-President, Investments - Life Sciences with the Fonds de solidarité FTQ, which he first joined in 2012. With net assets of ove...


New Mutual of Omaha Medicare Advantage Plans Now Available for Cincinnati-Area Seniors

Two new Medicare Advantage plans from Mutual of Omaha are now open for enrollment by seniors in the Greater Cincinnati area. Mutual of Omaha Care Advantage Complete and Mutual of Omaha Care Advantage Plus plans focus on wellness and high-quality care while offering benefits that include prescription and over-the-counter drug coverage, dental and v...

New Mutual of Omaha Medicare Advantage Plan Now Available for San Antonio-Area Seniors

A new Medicare Advantage plan from Mutual of Omaha is now open for enrollment by seniors in the Greater San Antonio area. Mutual of Omaha Care Advantage focuses on wellness and high-quality care while offering benefits that include prescription drug coverage, dental and vision care, and extras such as transportation to and from doctor appointments...

Videojet to Showcase Tools for Productivity Along with New Coding and Marking Solutions at Pack Expo International 2018

New Products Help Drive Improved Performance and More Predictable Operations Videojet Technologies, a global leader in coding, marking and variable data printing solutions, is highlighting its latest product innovations at the

Ligand to Report Third Quarter 2018 Results on November 8th

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report third quarter 2018 financial results on November 8, 2018. Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call. Third Quarter 2018 Earnings Call ...

Applied StemCell has Joined the NIST, Genome Editing Consortium

Applied StemCell, Inc. (ASC), a leading gene-editing company, announced that it has joined the National Institute of Standards and Technology (NIST) Genome Editing Consortium. Applied StemCell brings to the Consortium its expertise in TARGATTTM CRISPR/Cas9 gene-editing tools and induced pluripotent stem cell (iPSC) technology for the advancement of drug di...

Phase-Appropriate Validation of Bioassays to be Presented by Catalent at WCBBA Workshop

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that one of its scientific experts will host a workshop during KNect365 Life Sciences' annual Well Characterized Biologics & Biological Assays conference (WCBBA) at the Hilton Washington DC / Rockville Hotel &a...

Neuroscientists Use Rabies to Explore the Brain

Using engineered forms of the rabies virus, neuroscientists can map brain circuits with unprecedented precision -- Read more on ScientificAmerican.com

Global Tungsten Powder Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Ajinomoto announces 10% price increase on amino acid portfolio

Ajinomotoâs amino acid technologies division announced a 10% price increase across all of its markets due to rising causes of manufacturing and transportation.

NanoString Technologies Inc NSTG Medical Equipment Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryNanoString Technologies Inc NanoString is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and ...

Lilly Neuroscience Veteran David Bleakman Joins Redpin Therapeutics as Chief Scientific Officer

-- Company advancing novel platform technologies to enable non-invasive, targeted regulation of neuronal cell activity -- -- Aiming to address currently intractable neurologic and psychiatric diseases -- Redpin Therapeutics today announced the appointment of David Bleakman, PhD, as its Chief Scientific Officer (CSO). Founded in 2017, Redpin is...

HiFiBiO Therapeutics Acquires H-Immune Therapeutics

Companies join forces to target different T cell subsets and combat cancer HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, announced today the acquisition of H-Immune Therapeutics, an early-stage biotechnology company engaged in the discovery and development of novel imm...

Scientist.com’s Online Compliance Solution (COMPLi™) Wins Prestigious CPhl Pharma Award

Marketplace compliance tool takes top honors in Regulatory Procedures and Compliance category Scientist.com is pleased to announce its online compliance solution COMPLi™ was recognized as the winner of the prestigious Regulatory Procedures and Compliance award at the 2018 CPhl Pharma Awards held in Madrid, Spain on October 9, 2018. COMPLi™ i...

Global and Asia Polyethylene Foamed Plastics Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Peptilogics Receives Regulatory Approval to Initiate First-in-Human Safety Study for Therapeutic Peptide PLG0206

Therapeutic Development to Address Potential Orphan Indication and Global Pandemic Peptilogics, which develops peptide-based therapeutics with its computational biology platform, announced today that it has been cleared by Australia’s Therapeutics Goods Administration to begin the first in-human Phase 1 study of PLG0206, which is being developed to a...

Global Multifactor Authentication MFA Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Paragonix Technologies Inc., Announces Presentation of the Paragonix SherpaPak™ Cardiac Transport System at the 32nd Annual Meeting of the European Association for Cardio-Thoracic Surgery in Milan, 18-20 October 2018

Paragonix Technologies, Inc. will present the Paragonix SherpaPak™ Cardiac Transport System product line at Booth E08 during the 32nd Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS) held in Milan, Italy, from 18 to 20 October, 2018. The Paragonix SherpaPak™ CTS1,2 is intended for the transport of donor hearts destined for...

Applied Photophysics signs distribution agreement with Particular Sciences to expand coverage in Europe

Distributor will supply Chirascan circular dichroism spectrometers and SX stopped-flow spectrometers to Ireland and Northern Ireland Surrey, UK and Dublin, IRELAND, 15 October 2018: Applied Photophysics, a leading provider of systems for biophysical characterization of biomolecules, today announced that it has signed a distribution agreement with material characterisation specialist, Partic...

QIAGEN N.V. to Report Third Quarter and First Nine Months of 2018 Results

QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) plans as previously announced to release its report on results for the third quarter 2018 on Monday, October 29 shortly after 21:00 Central European Time (CET) / 16:00 Eastern Daylight Time (EDT). A conference call is planned for Tuesday, October 30 at 14:00 CET / 9:00 EDT hosted by Peer M. Schatz, Ch...

NIH Awards Allele with Grant for the Development of Nanoantibody Therapies for Treating Sepsis

The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody (nAb) therapies for the treatment of sepsis. Sepsis and septic shock are among the leading causes of death in intensive care units (ICUs). The global incidence...

Experimental bone engineered by researchers may help osteoarthritis patients

Researchers are developing an artificial bone that could in the future be used to treat osteoarthritis. The bifunctional composite is designed to compensate defects of both cartilage and bone. Made from hydroxyapatite, gelatine and chitosan, the scaffold imitates the complex structure and functionality of the joint and fills the fractures of the two different tissues. […] The post Experiment...

MGT Act Gives Pause to Reconsider the Mainframe for Government-Run Healthcare Organizations

IT consultants working with government-run healthcare organizations are getting many questions right now about the newly passed MGT Act, which carves out funds for government agencies to modernize their technologies. These agencies have just started applying for this funding, and as they ponder where to begin, many are looking squarely at the figurehead of so-called ... Read More


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks